Effect of Combined Natural Human β–lnterferon and Radiation on Human Tumor Cells

Oncology Research and Treatment

Volumn 19, Issue 6, 1996, Pages 501-504

  Busch, M ^a   Rave Frank M ^b   Franke, T ^b   Duhmke E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cell culture; Radiosensitization; Interferon

Indexed keywords

BETA INTERFERON;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

EID: 0030499001     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218863     Document Type: Article

References (20)

1. Mossmann KL, Hill LT, Dritschilo A: Utility of Interferons in clinical radiotherapy. J Natl Med Assoc 1982:74:1083-1087.
2. Byhardt RW: Can Interferon Beta make the radiation therapy team for treatment of non-small cell lung cancer? Int Rad Oncol Biol Phys 1993:27:753-756.
3. Angioli R. Sevin B-U, Pcrras JP. Untch M. Hightower RD, Nguyen HN. Steren A, Villani C. Averelte HE: Rationale of combining radiation and interferon for the treatment of cervical cancer. Oncology 1992: 49:445-449.
4. Angioli R. Sevin BU, Penas JP. Untch M, Kocchli OR. Nguyen HN. Steren A, Schwade JG. Villani C. Averctte HE: In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer lines. Cancer 1993:71:3717-3725.
5. Gould MN. Kakria RC. Olson S. Borden EC: Radiosensitization of human bronchogenic carcinoma cells by Interferon beta. J Interferon Res 1984:4:123-128.
6. Kakria RC, Gould MN. Borden EC, Olson S: Antiproliferative and radiosensiti/ing effect of interferons on human lung carcinoma cells. Proc 23rd Annu ASTR Meet Abstracts. 1983, p 1305.
7. Brandenburg K, Paul E, Renner H: Intrafokale Beta-Interferon-Therapie in Kombination mit Strahlenthe-rapie beim metastasicrenden malignen Melanom. Aktuelle Dermatol 1993;19-12:347-350.
8. McDonald S, Chang AY, Rubin P, Wallenberg J, Kim IS, Sobel S, Smith J, Keng P, Muhns A: Combined betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer. Int J Rad Oncol Biol Phys 1993:27:613-619.
9. Szepesi S, Jacobi V, Baew-Christow Th. Rahl CG: Intralasionale Behandlung fortgeschrittener Mam-makarzinom-Mctastascn mit (J-IFN allein und in Kombination mit moderat dosierter Radiotherapie; in Willcrt H-G. Heuck FHW (ed): Neuere Ergeb-nisse in der Osteologie. Berlin. Springer, 1989.
10. Friedrich R. Wildfang I. Schnalke D. Schmoll H-J. Emminger A: Intralesional beta-Interferon therapy and low dose radiotherapy (20 Gy) in the treatment of refractory metastasis from solid tumours. J Cancer Res Clin Oncol 1992:18:R104.
11. Chang AY. McDonald S. Kim Su III. Sobel S. Smith J. Boros L. Keng P. Rubin P: Phase l/II Study of combined radiation and Betaseron in the treatment of locally advanced non-small cell lung cancer (NSCLC). Medical and Radiation Oncology, Univ. of Rochester. USA (1989).
12. Chang AYC. Keng PC: Potention of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. Cancer Res 1987: 47:4338-4341.
13. Takakura K, Brain Tumour Research Group: Effect of combined treatment with Interferon-fS and che-moradiotherapy for malignant gliomas. J Interferon Res 1988:8:20.
14. Yoshida J. Kagcyama N: Combination of 1FN-ACNU-radiation (IAR) for postoperative adjuvant therapy against malignant glioma. Nagoya University School of Medicine, 1987.
15. Chang AY. Keng P: Radiation (XRT) sensitization by Interferons (IFNs), preclinical and clinical studies J Interferon Res 1987:7:681.
16. Rave-Frank M, Virsik-Peukcrt P, Bertram K, Schmidberger H: Chromosome analysis in primary cells of human squamous cell carcinoma by fluorescence in situ hybridization. Int J Radial Biol 1996 (in press).
17. Soule HD, Valzqucz J, Long A, Albert S. Brennan M: A human cell line from a pleural effusion derived from breast carcinoma. J Natl Cancer Inst 1973:51:1409-1416.
18. Dritschilo A. Mossman K. Gray M. Sreevalsan T: Potentiation of radiation injury by interferon. Am J Clin Oncol 1982:5:79-82.
19. Namba M, Yamamoto S, Tanaka H, Kanamori T, Nobuhara M, Kimoto T: In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt-60 gamma ray by interferon on human neoplastic cells. Cancer 1984:54:2262-2267.
20. Gould M, Kakria R, Olson S, Borden EC: Radiosensitization of human bronchogenic carcinoma cells by interferon. J Interferon Res 1984:4:123-128.